BIOMAT Database Logo BIOMAT Database Logo

Benzimidazole derivatives as tubulin polymerization inhibitors: Design, synthesis and in vitro cytotoxicity studies. 2023

Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India.

A new class of benzimidazole derivatives as tubulin polymerization inhibitors has been designed and synthesized in this study. The in vitro anticancer profile of the developed molecules was reconnoitred on selected human cancer cells. The highest cytotoxicity was illustrated by compounds 7n and 7u with IC50 values ranging from 2.55 to 17.89 µM with specificity toward SK-Mel-28 cells. They displayed 5-fold less cytotoxicity towards normal rat kidney epithelial NRK52E cells, which implies that they are not harmful to normal, healthy cells. The cellular staining procedures like AO/EB, DCFDA, and DAPI were applied to comprehend the inherent mechanism of apoptosis which displayed nuclear and morphological alterations. The Annexin V binding and JC-1 studies were executed to evaluate the extent of apoptosis and the decline in mitochondrial transmembrane potential in SK-Mel-28 cell lines. Compound 7n dose-dependently arrested the G2/M phase of the cell cycle and the target-based outcomes proposed tubulin polymerization inhibition by 7n (IC50 of 5.05±0.13 μM). Computational studies were also conducted on the tubulin protein (PDB ID: 3E22) to investigate the stabilized binding interactions of compounds 7n and 7u with tubulin, respectively.

UI MeSH Term Description Entries
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Design, synthesis and bioevaluation of novel trifluoromethylquinoline derivatives as tubulin polymerization inhibitors.
November 2023, Future medicinal chemistry,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors.
March 2023, RSC medicinal chemistry,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Structure-based approaches for the design of benzimidazole-2-carbamate derivatives as tubulin polymerization inhibitors.
July 2017, Chemical biology & drug design,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Design and synthesis of substituted dihydropyrimidinone derivatives as cytotoxic and tubulin polymerization inhibitors.
December 2019, Bioorganic chemistry,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Design, Synthesis and Evaluation of 2,4-Diaminoquinazoline Derivatives as Potential Tubulin Polymerization Inhibitors.
October 2020, ChemMedChem,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
N-substituted benzimidazole acrylonitriles as in vitro tubulin polymerization inhibitors: Synthesis, biological activity and computational analysis.
February 2021, European journal of medicinal chemistry,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors.
July 2019, European journal of medicinal chemistry,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Synthesis and biological evaluation of 2-aryl-benzimidazole derivatives of dehydroabietic acid as novel tubulin polymerization inhibitors.
May 2018, RSC advances,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Design and synthesis of aminostilbene-arylpropenones as tubulin polymerization inhibitors.
November 2014, ChemMedChem,
Kritika Laxmikeshav, and Ziaur Rahman, and Ashutosh Mahale, and Durgesh Gurukkala Valapil, and Pravesh Sharma, and Joel George, and Regur Phanindranath, and Manoj P Dandekar, and Onkar P Kulkarni, and Narayana Nagesh, and Nagula Shankaraiah
Design, synthesis and molecular docking of novel diarylcyclohexenone and diarylindazole derivatives as tubulin polymerization inhibitors.
December 2017, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!